| J9271 | Injection, pembrolizumab, 1 mg | 10,630 | $40 | $456.9K |
| J9299 | Injection, nivolumab, 1 mg | 6,310 | $20 | $145.1K |
| J0897 | Injection, denosumab, 1 mg | 6,950 | $20 | $125K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 780 | $110 | $84K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 600 | $140 | $81.5K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 710 | $70 | $51.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 320 | $160 | $49.8K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 10,380 | $1 | $20.8K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 870 | $20 | $19.2K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 240 | $70 | $15.7K |